Follow
Bruno Villoutreix
Bruno Villoutreix
Verified email at inserm.fr - Homepage
Title
Cited by
Cited by
Year
Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition
B Dahlbäck, BO Villoutreix
Arteriosclerosis, thrombosis, and vascular biology 25 (7), 1311-1320, 2005
4342005
The anticoagulant protein C pathway
B Dahlbäck, BO Villoutreix
FEBS letters 579 (15), 3310-3316, 2005
3972005
Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery
S Pérot, O Sperandio, MA Miteva, AC Camproux, BO Villoutreix
Drug discovery today 15 (15-16), 656-667, 2010
3192010
FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects
D Lagorce, O Sperandio, H Galons, MA Miteva, BO Villoutreix
BMC bioinformatics 9, 1-9, 2008
3082008
Toward in silico structure-based ADMET prediction in drug discovery
G Moroy, VY Martiny, P Vayer, BO Villoutreix, MA Miteva
Drug discovery today 17 (1-2), 44-55, 2012
3012012
FAF-Drugs3: a web server for compound property calculation and chemical library design
D Lagorce, O Sperandio, JB Baell, MA Miteva, BO Villoutreix
Nucleic acids research 43 (W1), W200-W207, 2015
3002015
Complement inhibitor C4b-binding protein—friend or foe in the innate immune system?
AM Blom, BO Villoutreix, B Dahlbäck
Molecular immunology 40 (18), 1333-1346, 2004
2732004
FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery
D Lagorce, L Bouslama, J Becot, MA Miteva, BO Villoutreix
Bioinformatics 33 (22), 3658-3660, 2017
2622017
Rationalizing the chemical space of protein–protein interaction inhibitors
O Sperandio, CH Reynès, AC Camproux, BO Villoutreix
Drug discovery today 15 (5-6), 220-229, 2010
2382010
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
F Bienaime, MA Dragon-Durey, CH Regnier, SC Nilsson, WH Kwan, ...
Kidney international 77 (4), 339-349, 2010
2182010
A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1
NV Prasadarao, AM Blom, BO Villoutreix, LC Linsangan
The Journal of Immunology 169 (11), 6352-6360, 2002
2152002
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
S Stoilova-McPhie, BO Villoutreix, K Mertens, G Kemball-Cook, ...
Blood, The Journal of the American Society of Hematology 99 (4), 1215-1223, 2002
2122002
MTiOpenScreen: a web server for structure-based virtual screening
CM Labbé, J Rey, D Lagorce, M Vavruša, J Becot, O Sperandio, ...
Nucleic acids research 43 (W1), W448-W454, 2015
2002015
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
D Lagorce, D Douguet, MA Miteva, BO Villoutreix
Scientific reports 7 (1), 46277, 2017
1842017
Structure-based virtual ligand screening: recent success stories
BO Villoutreix, R Eudes, MA Miteva
Combinatorial chemistry & high throughput screening 12 (10), 1000-1016, 2009
1722009
FAF-Drugs: free ADME/tox filtering of compound collections
MA Miteva, S Violas, M Montes, D Gomez, P Tuffery, BO Villoutreix
Nucleic acids research 34 (suppl_2), W738-W744, 2006
1592006
A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells
A Säfholm, K Leandersson, J Dejmek, CK Nielsen, BO Villoutreix, ...
Journal of Biological Chemistry 281 (5), 2740-2749, 2006
1542006
MS-DOCK: accurate multiple conformation generator and rigid docking protocol for multi-step virtual ligand screening
N Sauton, D Lagorce, BO Villoutreix, MA Miteva
BMC bioinformatics 9, 1-12, 2008
1502008
Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex
MA Miteva, WH Lee, MO Montes, BO Villoutreix
Journal of medicinal chemistry 48 (19), 6012-6022, 2005
1442005
Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods
C Reynès, H Host, AC Camproux, G Laconde, F Leroux, A Mazars, ...
PLoS computational biology 6 (3), e1000695, 2010
1432010
The system can't perform the operation now. Try again later.
Articles 1–20